Astria Therapeutics, Inc. (ATXS) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of$0.41. This compares to a loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -34.15$0.61 per share when it actually produced a loss of $0.57, delivering a surprise of +6.56%.Over the last four quarters, the company ...